These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Physicochemical Profiling and Comparison of Research Antiplasmodials and Advanced Stage Antimalarials with Oral Drugs. Bhanot A; Sundriyal S ACS Omega; 2021 Mar; 6(9):6424-6437. PubMed ID: 33718733 [TBL] [Abstract][Full Text] [Related]
4. Nanoparticle and iron chelators as a potential novel Alzheimer therapy. Liu G; Men P; Perry G; Smith MA Methods Mol Biol; 2010; 610():123-44. PubMed ID: 20013176 [TBL] [Abstract][Full Text] [Related]
5. Novel diaroylhydrazine ligands as iron chelators: coordination chemistry and biological activity. Bernhardt PV; Chin P; Sharpe PC; Wang JY; Richardson DR J Biol Inorg Chem; 2005 Nov; 10(7):761-77. PubMed ID: 16193304 [TBL] [Abstract][Full Text] [Related]
6. Iron chelators for clinical use. Tilbrook GS; Hider RC Met Ions Biol Syst; 1998; 35():691-730. PubMed ID: 9444773 [No Abstract] [Full Text] [Related]
7. Novel double prodrugs of the iron chelator N,N'-bis(2-hydroxybenzyl)ethylenediamine-N,N'-diacetic acid (HBED): Synthesis, characterization, and investigation of activation by chemical hydrolysis and oxidation. Thiele NA; Abboud KA; Sloan KB Eur J Med Chem; 2016 Aug; 118():193-207. PubMed ID: 27128183 [TBL] [Abstract][Full Text] [Related]
8. A Double Prodrug with Improved Membrane Permeability over the Parent Chelator HBED Provides Superior Cytoprotection against Hydrogen Peroxide. Thiele NA; Sloan KB ChemMedChem; 2016 Aug; 11(15):1596-9. PubMed ID: 27440560 [TBL] [Abstract][Full Text] [Related]
9. Caco-2 cell permeability of a new (hydroxybenzyl)ethylenediamine oral iron chelator: correlation with physicochemical properties and oral activity. Lowther N; Tomlinson B; Fox R; Faller B; Sergejew T; Donnelly H J Pharm Sci; 1998 Sep; 87(9):1041-5. PubMed ID: 9724552 [TBL] [Abstract][Full Text] [Related]
10. HBED: the continuing development of a potential alternative to deferoxamine for iron-chelating therapy. Bergeron RJ; Wiegand J; Brittenham GM Blood; 1999 Jan; 93(1):370-5. PubMed ID: 9864183 [TBL] [Abstract][Full Text] [Related]
11. Chemical evaluation of HBED/Fe(3+) and the novel HJB/Fe(3+) chelates as fertilizers to alleviate iron chlorosis. López-Rayo S; Hernández D; Lucena JJ J Agric Food Chem; 2009 Sep; 57(18):8504-13. PubMed ID: 19689133 [TBL] [Abstract][Full Text] [Related]
12. Improving the oral bioavailability of the iron chelator HBED by breaking the symmetry of the intramolecular H-bond network. Faller B; Spanka C; Sergejew T; Tschinke V J Med Chem; 2000 Apr; 43(8):1467-75. PubMed ID: 10780902 [TBL] [Abstract][Full Text] [Related]